About SPL
Starpharma Holdings Limited (SPL) is a biotechnology company with over 20 years of experience in developing dendrimer technology for pharmaceutical applications. Their mission is to help patients with significant illnesses, such as cancer, achieve improved health outcomes and quality of life through the application of their unique dendrimer technology.
Find out what a historical investment in Starpharma Holdings would be worth today using our SPL stock calculator.
Market Capitalisation
$405.38M
Price-earnings ratio
-46.91
Dividend yield
-
High today
$0.85
Low today
$0.83
Open price
$0.84
52-week high
$0.88
52-week low
$0.24
Ready to start your investing journey with Stake?
Open an accountAnnouncements
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in SPL
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in SPL on Stake
- Buy SPL from A$3 brokerage
- Invest in 2,500+ Aussie stocks and ETFs
- CHESS-sponsored ASX trades
Stock shown for demonstrative purposes only. A$3 brokerage up to A$30,000.
SPL related stocks